INR:0132. online swiss casino Puma's targeted anticancer drug Nerlynx receives FDA orphan drug designation for the treatment of breast cancer brain metastases ...
Shares of Puma Biotechnology, Inc. PBYI have rallied 24% in the past three months against the industry’s decline of 9.7%. The company’s sole marketed product, Nerlynx (neratinib), is approved ...
Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Cervical Cancer were updated to include an addition involving neratinib (NERLYNX®). The updated NCCN Practice Guidelines for ...